|Podcasts|June 24, 2021
Predicting Supply Risk and Disruption
Author(s)Nicholas Saraceno, Editor, Michael Christel
C-suite executive shares knowledge surrounding data security and risk mitigation
Advertisement
Atul Vashishta, founder and CEO of Supply Wisdom, a company that delivers continuous risk intelligence, discusses his story in starting up the business, how he identified early risk indicators for Covid disruption, industry approaches to cybersecurity and plenty more.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Longer-Term Impact of MFN Pricing
2
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
3
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
4
Trade & Channel Strategies 2025: Topics of Interest
5
